Simplex Trading’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	106,200 -66,100	-38%	-$835K	﹤0.01%	2316
2025 Q4	$2.86M	Buy	172,300 +111,500	+183%	+$1.59M	﹤0.01%	1694
2025 Q3	$715K	Sell	60,800 -48,100	-44%	-$496K	﹤0.01%	3394
2025 Q2	$1.04M	Buy	108,900 +100,100	+1,138%	+$554K	﹤0.01%	2731
2025 Q1	$55K	Buy	+8,800	New	+$53.4K	﹤0.01%	5672
2024 Q4	–	Sell	-9,500	Closed	-$171K	–	9363
2024 Q3	$171K	Sell	9,500 -23,900	-72%	-$334K	﹤0.01%	4677
2024 Q2	$344K	Buy	33,400 +2,000	+6%	+$20.6K	﹤0.01%	4073
2024 Q1	$333K	Buy	31,400 +18,400	+142%	+$156K	﹤0.01%	4275
2023 Q4	$118K	Sell	13,000 -33,100	-72%	-$285K	﹤0.01%	5220
2023 Q3	$478K	Buy	46,100 +11,100	+32%	+$152K	﹤0.01%	3449
2023 Q2	$501K	Buy	35,000 +20,600	+143%	+$238K	﹤0.01%	3317
2023 Q1	$102K	Buy	14,400 +9,900	+220%	+$87K	﹤0.01%	5132
2022 Q4	$50K	Buy	4,500 +500	+13%	+$5.16K	﹤0.01%	5903
2022 Q3	$44K	Buy	4,000 +2,400	+150%	+$22.9K	﹤0.01%	6625
2022 Q2	$13K	Sell	1,600 -1,700	-52%	-$17.5K	﹤0.01%	8060
2022 Q1	$44K	Buy	3,300 +2,000	+154%	+$32.3K	﹤0.01%	7317
2021 Q4	$25K	Buy	+1,300	New	+$30.6K	﹤0.01%	8121